Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tao Che

Showing results (231-240 of 250) with videos related to

Pageof 25
Sort By:
Journal of Ethnopharmacology|September 30, 2021
Alkaloid-rich fraction of Ervatamia coronaria sensitizes colorectal cancer through modulating AMPK and mTOR signalling pathwaysNaibedya Dutta, Deepak Bharadwaj Pemmaraju, Suvranil Ghosh, et al.
Neuropharmacology|June 21, 2021
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effectsKerri D Pryce, Hye Jin Kang, Farhana Sakloth, et al.
Nature Chemical Biology|November 21, 2022
Insights into distinct signaling profiles of the µOR activated by diverse agonistsQianhui Qu, Weijiao Huang, Deniz Aydin, et al.
Autophagy|January 21, 2010
Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cellsWilliam Ka Kei Wu, Chi Hin Cho, Chung Wa Lee, et al.
Biomedical Chromatography : BMC|May 27, 2016
Interaction effects on cytochrome P450 both in vitro and in vivo studies by two major bioactive xanthones from Halenia elliptica D. DonRu Feng, Xiang-Shan Tan, Bao-Ying Wen, et al.
Journal of Medicinal Chemistry|June 11, 2025
Searching for Synthetic Opioid Rescue Agents. 2: Identification of an Ultra-Potent Synthetic Opioid Rescue AgentJocelyn Martin, Edem Onyameh, Dan Luo, et al.
Trials|June 3, 2014
Effectiveness guidance document (EGD) for Chinese medicine trials: a consensus documentClaudia M Witt, Mikel Aickin, Daniel Cherkin, et al.
Nature|February 11, 2020
Virtual discovery of melatonin receptor ligands to modulate circadian rhythmsReed M Stein, Hye Jin Kang, John D McCorvy, et al.
Nature Communications|December 6, 2023
Docking for EP4R antagonists active against inflammatory painStefan Gahbauer, Chelsea DeLeon, Joao M Braz, et al.
Nature|July 3, 2024
A µ-opioid receptor modulator that works cooperatively with naloxoneEvan S O'Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Journal of Ethnopharmacology|September 30, 2021
Alkaloid-rich fraction of Ervatamia coronaria sensitizes colorectal cancer through modulating AMPK and mTOR signalling pathwaysNaibedya Dutta, Deepak Bharadwaj Pemmaraju, Suvranil Ghosh, et al.
Neuropharmacology|June 21, 2021
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effectsKerri D Pryce, Hye Jin Kang, Farhana Sakloth, et al.
Nature Chemical Biology|November 21, 2022
Insights into distinct signaling profiles of the µOR activated by diverse agonistsQianhui Qu, Weijiao Huang, Deniz Aydin, et al.
Autophagy|January 21, 2010
Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cellsWilliam Ka Kei Wu, Chi Hin Cho, Chung Wa Lee, et al.
Biomedical Chromatography : BMC|May 27, 2016
Interaction effects on cytochrome P450 both in vitro and in vivo studies by two major bioactive xanthones from Halenia elliptica D. DonRu Feng, Xiang-Shan Tan, Bao-Ying Wen, et al.
Journal of Medicinal Chemistry|June 11, 2025
Searching for Synthetic Opioid Rescue Agents. 2: Identification of an Ultra-Potent Synthetic Opioid Rescue AgentJocelyn Martin, Edem Onyameh, Dan Luo, et al.
Trials|June 3, 2014
Effectiveness guidance document (EGD) for Chinese medicine trials: a consensus documentClaudia M Witt, Mikel Aickin, Daniel Cherkin, et al.
Nature|February 11, 2020
Virtual discovery of melatonin receptor ligands to modulate circadian rhythmsReed M Stein, Hye Jin Kang, John D McCorvy, et al.
Nature Communications|December 6, 2023
Docking for EP4R antagonists active against inflammatory painStefan Gahbauer, Chelsea DeLeon, Joao M Braz, et al.
Nature|July 3, 2024
A µ-opioid receptor modulator that works cooperatively with naloxoneEvan S O'Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Pageof 25